Abstract
There are experimental data showing beneficial actions of inositol and inositol hexaphosphate (InsP6) in Alzheimer’s disease and Parkinson’s disease. The different stereoisomers of inositol, myo-, epi-, scyllo- and chiro-inositol have shown efficacy in Alzheimer’s disease. The antioxidant and cation chelating properties of InsP6 are considered to be some of the mechanisms; those of myo-inositol are not clear. Insofar as psychiatric diseases, lithium salts have been in use since the 1950s for bipolar disorder. While on one hand there is reduction of myo-inositol by lithium, myo-inositol on the other hand has been found useful in psychiatric disorders, and at least in one study of bipolar disorder. Thus, further studies of myo-inositol, and InsP6 in the treatment of bipolar disorder are warranted. A clinical trial of InsP6 in bipolar disorder is underway.
Keywords: Alzheimer’s disease, BACE 1, bipolar disorder, CGI-S, HAM-D, Levodopa, lithium, MADRS, OCD, panic disorder, Parkinson’s disease, Y-BOCS.
Related Books
Advances in Physicochemical Properties of Biopolymers (Part 1)
Advances in Physicochemical Properties of Biopolymers (Part 2)
Biochemical Mechanisms of Aluminium Induced Neurological Disorders
Biochemistry: Fundamentals and Bioenergetics
Biology and Chemistry of Beta Glucan Volume Title: Beta-Glucan, Structure, Chemistry and Specific Application
Biology and Chemistry of Beta Glucan Vol: 1 Beta Glucans - Mechanisms of Action
Cutting Edge Techniques in Biophysics, Biochemistry and Cell Biology: From Principle to Applications
Essential Techniques for Medical and Life Scientists: A Guide to Contemporary Methods and Current Applications with the Protocols: Part I
Essential Techniques for Medical and Life Scientists: A Guide to Contemporary Methods and Current Applications- Part II
Evaluation of Cellular Processes by In Vitro Assays